Chlorpromazine and clothiapine actions at the level of the CNS and vas deferens
Pérez Raya, M.D.; Zarzuelo, A.; Duarte, J.M.; Jiménez, J.; Navarro, C.
Pharmaceutica Acta Helvetiae 65(8): 228-232
1990
ISSN/ISBN: 0031-6865 PMID: 1978353 Document Number: 351181
CNS-level changes caused by chlorpromazine and clothiapine, a structural analogue, were studied with a battery of behavioral tests in rats, along with the ability of these two drugs to antagonize electrically and alpha-stimulator (phenylephrine-)induced contractions in the rat vas deferens. The findings indicated that clothiapine, while less effective as an alpha-receptor antagonist, was a much more active CNS-depressant than chlorpromazine.
Document emailed within 1 workday
Related Documents
Lucchelli, A.; Santagostino-Barbone, M.G.; Modesto, F.; Grana, E. 1984: Direct and indirect actions of 5-hydroxytryptamine on the rat isolated vas deferens Archives Internationales de Pharmacodynamie et de Therapie 269(2): 236-251Vetulani, J. 1973: The action of neuroleptics in rats with altered catecholamine metabolism. I. the influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine Polish Journal of Pharmacology and Pharmacy 25(1): 41-52
Przyborowska, M.; Szumiło, H.; Misztal, G.; Olajossy, M. 1985: Determining the serum level of chlorpromazine by high-performance liquid chromatography Acta Poloniae Pharmaceutica 42(5): 467-472
Forrest, I.S.; Green, D.E.; Serra, M.T.; Soave, O.A. 1975: Chlorpromazine excretion in chronically dosed primates. I. Occurrence of a previously unreported class of chlorpromazine conjugates Psychopharmacology Communications 1(1): 51-59
Chaudhary, A.K.; Hubbard, J.W.; McKay, G.; Midha, K.K. 1988: Identification of a quaternary ammonium-linked glucuronide of chlorpromazine in the urine of a schizophrenic patient treated with chlorpromazine Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(3): 506-508
Brueschke, E.E.; Burns, M.; Maness, J.H.; Wingfield, J.R.; Mayerhofer, K.; Zaneveld, L.J. 1974: Development of a reversible vas deferens occlusive device. I. Anatomical size of the human and dog vas deferens Fertility and Sterility 25(8): 659-672
Ozawa, H.; Abe, F. 1974: Method of separating the vas deferens from the ganglion in a hypogastric nerve-vaso deferens preparation of the guinea pig Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(5): 727-733
Vencovský, E.; Peterová, E.; Baudis, P. 1970: Current clinical experience with clothiapine (Entumin) Ceskoslovenska Psychiatrie 66(2): 93-97
García Roldán, J.L.; Dueñas Laita, A.; González Martínez de Zárate, J.L.; Velasco-Martín, A. 1983: Effect of clothiapine on oxidative metabolism of rat brain in vitro Il Farmaco; Edizione Pratica 38(6): 243-249
Ropert, R. 1973: Clothiapine: neuroleptic with predominantly sedative action. its use by injection in acute psychiatric syndromes L'Encephale 62(2): 190-200
Kiriakov, A.; Khlebarova, M.; Staneva-stoicheva, D.; Panova, I. 1975: The effect of prolonged treatment of hypertensive rats with antihypertensive drugs of various actions on the arterial tension and noradrenaline level in the myocardium, brain and aortal Eksperimentalna Meditsina i Morfologiia 14(1): 7-12
Tsai, J.C.; Knoblich, G.; Sebanz, N. 2010: From action expertise to shared action plans: Inclusion of non-controlled actions at the intra- and inter-personal level International Journal of Psychophysiology 77(3): 332-333
2012: Physician disciplinary actions by state. Ranked by total board actions in 2011 Modern healthcare 42(43): 45
Aoyagi, T.; Wada, T.; Ohuchi, S.; Kawamura, K.; Fukatsu, S.; Umezawa, H. 1984: In vivo actions of bestatin-related compounds in relation to their actions in vitro Biochemistry International 9(5): 643-650
Koda, A.; Nishiyori, T.; Nagai, H.; Matsuura, N.; Tsuchiya, H. 1982: Anti-allergic actions of traditional oriental medicine--actions against types i and IV hypersensitivity reactions Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 80(1): 31-41
Grzybowski, A. 2006: The history of antitobacco actions in the last 500 years. Part. II. Medical actions Przeglad Lekarski 63(10): 1131-1134
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556
Rodriguez Pizarro, A.N. 2005: Acciones colectivas en el conflicto político colombiano : ¿De guerrilla a grupos terroristas? El caso del ELN - Collective actions in the Colombian political conflict : From guerrilla to terrorist groups? The study of ELN - Actions collectives dans le conflit politique colombien: De la guerilla aux groupes terroristes? Le cas de l'ELN Politica y Sociedad (Madrid) 42(2): 133-147
Luo, L.; Waang, Y.; Sun, M.; Su, Z-Xin.; Ma, N.; Xie, H.; Wang, W.; Yu, J.; Yu, M.; Duan, Y.; Gong, X.; Chen, Z.; Wang, H.; Shi, P.; Liang, Z.; Yang, F.; Wang, D.; Yue, J.; Luo, S.; Hao, M. 2006: Study on manpower allocation criteria of center of disease prevention and control in the context of province level, city level and county level Wei Sheng Yan Jiu 35(1): 1-3
Phadke, G.M. 1961: Re-anastomosis of the vas deferens Journal of the Indian Medical Association 36: 386-390